4//SEC Filing
Tarriff Scott 4
Accession 0000950170-24-023945
CIK 0000827871other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:40 PM ET
Size
5.9 KB
Accession
0000950170-24-023945
Insider Transaction Report
Form 4
Tarriff Scott
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2024-02-28$6.27/sh−2,119$13,286→ 460,621 total
Holdings
- 992,623(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on February 28, 2024.
- [F2]Shares held by the Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016 (the "Trust") for the benefit of the Reporting Person's spouse and children. The Reporting Person does not have investment control over the shares held by the Trust and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001469124
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 4:40 PM ET
- Size
- 5.9 KB